At a glance
- Originator Fujisawa
- Developer Fujisawa; Nonindustrial source
- Class Ischaemic heart disorder therapies; Small molecules
- Mechanism of Action Adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 16 Jun 1995 No-Development-Reported for Angina pectoris in Japan (Unknown route)
- 16 Jun 1995 No-Development-Reported for Angina pectoris in USA (Unknown route)